Unity Biotechnology Stock Price To Earnings To Growth
| UBX Stock | USD 1.55 0.01 0.64% |
Unity Biotechnology fundamentals help investors to digest information that contributes to Unity Biotechnology's financial success or failures. It also enables traders to predict the movement of Unity Stock. The fundamental analysis module provides a way to measure Unity Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Unity Biotechnology stock.
Unity | Price To Earnings To Growth |
Unity Biotechnology Company Price To Earnings To Growth Analysis
Unity Biotechnology's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Unity Price To Earnings To Growth Driver Correlations
Understanding the fundamental principles of building solid financial models for Unity Biotechnology is extremely important. It helps to project a fair market value of Unity Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Unity Biotechnology's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Unity Biotechnology's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Unity Biotechnology's interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Unity Price Earnings To Growth Ratio
Price Earnings To Growth Ratio |
|
Based on the latest financial disclosure, Unity Biotechnology has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Unity Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Unity Biotechnology's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Unity Biotechnology could also be used in its relative valuation, which is a method of valuing Unity Biotechnology by comparing valuation metrics of similar companies.Unity Biotechnology is currently under evaluation in price to earnings to growth category among related companies.
Unity Fundamentals
| Return On Equity | -0.94 | ||||
| Return On Asset | -0.25 | ||||
| Current Valuation | 9.47 M | ||||
| Shares Outstanding | 16.79 M | ||||
| Shares Owned By Insiders | 1.33 % | ||||
| Shares Owned By Institutions | 28.56 % | ||||
| Number Of Shares Shorted | 310.27 K | ||||
| Price To Book | 0.70 X | ||||
| Price To Sales | 7.89 X | ||||
| Gross Profit | (35.22 M) | ||||
| EBITDA | (38.98 M) | ||||
| Net Income | (39.86 M) | ||||
| Cash And Equivalents | 64.51 M | ||||
| Cash Per Share | 9.26 X | ||||
| Total Debt | 26.99 M | ||||
| Debt To Equity | 1.30 % | ||||
| Current Ratio | 4.13 X | ||||
| Book Value Per Share | 1.69 X | ||||
| Cash Flow From Operations | (38.65 M) | ||||
| Short Ratio | 5.94 X | ||||
| Earnings Per Share | (2.67) X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 19 | ||||
| Beta | 0.86 | ||||
| Market Capitalization | 26.02 M | ||||
| Total Asset | 65.69 M | ||||
| Retained Earnings | (484.35 M) | ||||
| Working Capital | 38.77 M | ||||
| Net Asset | 65.69 M |
About Unity Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Unity Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Unity Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Unity Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Unity Biotechnology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Unity Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unity Biotechnology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unity Biotechnology Stock:Check out Unity Biotechnology Piotroski F Score and Unity Biotechnology Altman Z Score analysis. For more information on how to buy Unity Stock please use our How to Invest in Unity Biotechnology guide.Note that the Unity Biotechnology information on this page should be used as a complementary analysis to other Unity Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Unity Stock analysis
When running Unity Biotechnology's price analysis, check to measure Unity Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unity Biotechnology is operating at the current time. Most of Unity Biotechnology's value examination focuses on studying past and present price action to predict the probability of Unity Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unity Biotechnology's price. Additionally, you may evaluate how the addition of Unity Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is Unity Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Unity Biotechnology. If investors know Unity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Unity Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.67) | Quarterly Revenue Growth (1.00) | Return On Assets (0.25) | Return On Equity (0.94) |
The market value of Unity Biotechnology is measured differently than its book value, which is the value of Unity that is recorded on the company's balance sheet. Investors also form their own opinion of Unity Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Unity Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Unity Biotechnology's market value can be influenced by many factors that don't directly affect Unity Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Unity Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Unity Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Unity Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.